Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    GLYX13-C-202
Show Display Options
Rank Status Study
1 Not yet recruiting Open Label Extension for GLYX13-C-202, NCT01684163
Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13
2 Active, not recruiting Phase 2, Double-Blind, Placebo Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: GLYX-13;   Drug: Placebo

Indicates status has not been verified in more than two years